Astro-Med (NASDAQ: ALOT) reported Q3 EPS of $0.21. Revenue for the quarter came in at $28.8 million, versus $0 reported last year.

Third-Quarter Fiscal 2018 Highlights (comparisons with third-quarter fiscal 2017)

• Bookings up 38.2% to $31.2 million
• Revenue up 23.2% to $28.8 million on strong international growth
• EPS up 40% to $0.21
• Backlog up 27.5% to $21.3 million at quarter end

Business Outlook

“Looking ahead, we are focused on driving organic growth through product innovation and geographic expansion, complemented by strategic acquisitions that advance our Product Identification and Test & Measurement growth objectives,” Woods concluded. “We are well positioned as we conclude fiscal 2018.”

For earnings history and earnings-related data on Astro-Med (ALOT) click here.